lapatinib
Ligand Summary
A quinazoline derivative that inhibits EPIDERMAL GROWTH FACTOR RECEPTOR and HER2 (RECEPTOR, ERBB-2) tyrosine kinases. It is used for the treatment of advanced or metastatic breast cancer, where tumors overexpress HER2.
UNII: 0VUA21238F
PubChem: 208908
PubChem: 11557040
Guide to Pharmacology: 5692
ChEMBL: CHEMBL554
ChEMBL: CHEMBL1201179
DrugCentral: 1548
LyCHI: 3GTG4JMBXQKW
Target Activities
109 Activities
Items per page:
1 – 10 of 109
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
Kd | ||||||
IC50 | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||